postoperative aspiration pneumonia among adults using glp-1 receptor agonists Potential Use of and GIP/GLP-1 for Respiratory Disorders: Where Are We at? The science of safety: adverse

The American Society of Anesthesiologists (ASA) recommends withholding these drugs before surgery, but definitive guidelines remain unclear

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

Cayman offers these agents for research use only to support research in metabolic diseases like T2D and obesity